Hemophilia A and B: molecular and clinical similarities and differences

被引:127
作者
Castaman, Giancarlo [1 ]
Matino, Davide [2 ,3 ]
机构
[1] Careggi Univ Hosp, Ctr Bleeding Disorders & Coagulat, Dept Oncol, Florence, Italy
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
关键词
FC FUSION PROTEIN; V-LEIDEN MUTATION; FACTOR-IX; FACTOR-VIII; BLEEDING PHENOTYPE; IMMUNE TOLERANCE; LESS SEVERE; RISK; SEVERITY; BINDING;
D O I
10.3324/haematol.2019.221093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1702 / 1709
页数:8
相关论文
共 54 条
[31]  
Ludlam CA, 2000, HAEMOPHILIA, V6, P494
[32]   Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A [J].
Mahlangu, Johnny ;
Powell, Jerry S. ;
Ragni, Margaret V. ;
Chowdary, Pratima ;
Josephson, Neil C. ;
Pabinger, Ingrid ;
Hanabusa, Hideji ;
Gupta, Naresh ;
Kulkarni, Roshni ;
Fogarty, Patrick ;
Perry, David ;
Shapiro, Amy ;
Pasi, K. John ;
Apte, Shashikant ;
Nestorov, Ivan ;
Jiang, Haiyan ;
Li, Shuanglian ;
Neelakantan, Srividya ;
Cristiano, Lynda M. ;
Goyal, Jaya ;
Sommer, Jurg M. ;
Dumont, Jennifer A. ;
Dodd, Nigel ;
Nugent, Karen ;
Vigliani, Gloria ;
Luk, Alvin ;
Brennan, Aoife ;
Pierce, Glenn F. .
BLOOD, 2014, 123 (03) :317-325
[33]   The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH [J].
Mancuso, M. E. . ;
Bidlingmaier, C. ;
Mahlangu, J. N. ;
Carcao, M. ;
Tosetto, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) :2106-2110
[34]   Is haemophilia B less severe than haemophilia A? [J].
Mannucci, P. M. ;
Franchini, M. .
HAEMOPHILIA, 2013, 19 (04) :499-502
[35]  
Matino D., 2017, RES PRACT THROMB HAE, V1, P1
[36]   Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A [J].
Melchiorre, Daniela ;
Linari, Silvia ;
Manetti, Mirko ;
Romano, Eloisa ;
Sofi, Francesco ;
Matucci-Cerinic, Marco ;
Carulli, Christian ;
Innocenti, Massimo ;
Ibba-Manneschi, Lidia ;
Castaman, Giancarlo .
HAEMATOLOGICA, 2016, 101 (02) :219-225
[37]   Comparing bleed frequency and factor concentrate use between haemophilia A and B patients [J].
Nagel, K. ;
Walker, I. ;
Decker, K. ;
Chan, A. K. C. ;
Pai, M. K. .
HAEMOPHILIA, 2011, 17 (06) :872-874
[38]   New developments in the management of moderate-to-severe hemophilia B [J].
Nazeef, Moniba ;
Sheehan, John P. .
JOURNAL OF BLOOD MEDICINE, 2016, 7 :27-38
[39]   Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations [J].
Pinotti, Mirko ;
Caruso, Pierpaolo ;
Canella, Alessandro ;
Campioni, Matteo ;
Tagariello, Giuseppe ;
Castaman, Giancarlo ;
Giacomelli, Sofia ;
Belvini, Donata ;
Bernardi, Francesco .
HUMAN MUTATION, 2012, 33 (09) :1373-1376
[40]   Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B [J].
Powell, Jerry S. ;
Pasi, K. John ;
Ragni, Margaret V. ;
Ozelo, Margareth C. ;
Valentino, Leonard A. ;
Mahlangu, Johnny N. ;
Josephson, Neil C. ;
Perry, David ;
Manco-Johnson, Marilyn J. ;
Apte, Shashikant ;
Baker, Ross I. ;
Chan, Godfrey C. ;
Novitzky, Nicolas ;
Wong, Raymond S. ;
Krassova, Snejana ;
Allen, Geoffrey ;
Jiang, Haiyan ;
Innes, Alison ;
Li, Shuanglian ;
Cristiano, Lynda M. ;
Goyal, Jaya ;
Sommer, Jurg M. ;
Dumont, Jennifer A. ;
Nugent, Karen ;
Vigliani, Gloria ;
Brennan, Aoife ;
Luk, Alvin ;
Pierce, Glenn F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24) :2313-2323